Clinical Trial Update: Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes [Phase 2]

View source ↗

Summary

Completed Phase 2 clinical trial evaluating the safety, pharmacokinetics, and efficacy of CVT-301 (levodopa inhalation powder) for treating 'off' episodes in in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• CVT-301 (Inbrija) (levodopa inhalation powder)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Idiopathic Parkinson's Disease | Phase 2 | Status: COMPLETED